---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-006283"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2024-01-24T23:59:59+00:00"
generated_at: "2026-06-06T19:13:02.663433+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nutex Health raises $10M via 66.7M share/warrant offering at $0.15/unit

## Summary
- Offering of 66.7M shares and warrants on a 1:1 basis at $0.15 per unit; gross proceeds ~$10M.
- Closing expected Jan 25, 2024; Maxim Group LLC acts as placement agent with 7% fee.
- Net proceeds for working capital, hospital facility development, and IPA expansion.
- Warrants exercisable at $0.15 for 5 years; beneficial ownership cap of 4.99% (or 9.99% at holder's election).
- Risk factors updated: warns of need for additional capital, potential hospital closures, and NSA reimbursement declines.

## SEC filing metadata
- accession: 0001104659-24-006283
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2024-01-24T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000110465924006283/0001104659-24-006283-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000110465924006283/tm243990d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-006283
- JSON: https://secwatch.observer/filing/0001104659-24-006283.json
- Plain text: https://secwatch.observer/filing/0001104659-24-006283.txt

## Key facts
- Material Agreements
  Nutex Health Inc. entered into Placement Agency Agreement with Maxim Group LLC (effective 2024-01-22).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Maxim Group LLC
  - Effective: 2024-01-22
  source text: On January 22, 2024, the Company entered into a placement agency agreement with Maxim Group LLC (the “Placement Agent”) (the “Placement Agency Agreement”), pursuant to which the Company has agreed to pay the Placement Agent an aggregate fee equal to 7% of the aggregate gross proceeds received by the Company from the sale of the Shares and Warrants in the offering.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479681/000110465924006283/0001104659-24-006283-index.htm
- Material Agreements
  Nutex Health Inc. entered into Securities Purchase Agreement with a single healthcare focused institutional investor valued at approximately $10 million (effective 2024-01-22).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: a single healthcare focused institutional investor
  - Value: approximately $10 million
  - Effective: 2024-01-22
  source text: On January 22, 2024, Nutex Health Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single healthcare focused institutional investor for the sale by the Company of 66,666,666 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share, and warrants (the “Warrants”) to purchase 66,666,666 shares of the Company’s common stock.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479681/000110465924006283/0001104659-24-006283-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.